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Atrial Fibrillation – Clinical Issues
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Aims Multisite atrial pacing has been suggested to be effective in suppressing atrial fibrillation (AF), however, the effect of
linear triple-site atrial pacing (LTSP) in humans has not been evaluated. We compared the effects of LTSP to single-
site atrial pacing (SSP) on the atrial activation and wavefront propagation pattern in patients with persistent AF.
Methods
and results
In 10 patients with persistent AF, the effects of LTSP and SSP were evaluated by left atrial (LA) endocardial non-
contact multielectrode array mapping and multipolar catheters. LTSP and SSP were delivered from the high right
atrium (HRA), the distal coronary sinus (CS), and within the LA at the site showing maximal overlay of low-
voltage zones during sinus rhythm and pacing at HRA and CS. Atrial activation time and pattern, P wave duration,
and the prevention of AF induced by burst pacing were assessed with these pacing interventions. Compared with
SSP, LTSP at the HRA, CS, and LA shortened atrial activation times (183+ 24 vs. 174+24 ms, 186+29 vs.
166+28 ms, and 171+ 40 vs. 163+ 39 ms; P, 0.05, respectively). P wave duration was shorter with LTSP than
SSP at all three sites (141.7+ 35.1 vs. 146.9+ 38.5 ms, 138.1+34.6 vs. 145.7+ 33.7 ms, and 142.7+33.4 vs.
151.3+ 35.1 ms; P, 0.05, respectively). LTSP initially depolarized a larger area than SSP, and produced more
uniform and planar wavefront propagation. LTSP prevented the burst-induction of AF during LA pacing in 3 of 10
patients, while SSP was never successful.
Conclusion In patients with persistent AF, LTSP provided more rapid and uniform activation of the atria compared with SSP,
which was associated with prevention of burst-induction of AF in some patients. Further study is required to deter-
mine whether LTSP can modify the substrate of chronic AF, leading to frank AF suppression.
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Introduction
Current therapeutic interventions for atrial fibrillation (AF) include
various antiarrhythmic drug (AAD) therapies, and catheter-based
ablative and surgical procedures. Unfortunately, these therapies
have demonstrated only limited efficacy in treating AF, especially
in preventing recurrent AF. Also, these interventions carry poten-
tial significant adverse effects. One experimental study demon-
strated that right atrial (RA)-based linear triple-site pacing (LTSP)
significantly reduced the RA and biatrial activation times compared
with single-site pacing (SSP).1 Furthermore, it has been suggested
that shortening of atrial activation time and multidirectional exci-
tation by triple-site pacing contribute to AF suppression.2
However, the underlying electrophysiological mechanisms respon-
sible for AF suppression by atrial pacing remain unclear, and LTSP
pacing has not been investigated in humans. Therefore, we hypoth-
esized that LTSP would reduce atrial activation time and provide
for more uniform wavefront propagation over the atria compared
with SSP in patients with persistent AF, subsequently resulting in
improved prevention of burst-induction of AF. The purpose of
* Corresponding author. Tel: þ82 2 920 5445; fax: þ82 2 927 1478, Email: yhkmd@unitel.co.kr
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this study is to compare the effects of LTSP to SSP on atrial acti-
vation and AF inducibility in substrate-dominant chronic AF.
Methods
Patient selection
The investigational institution (Korea University Medical Center, Seoul,
Korea) attempted to recruit consecutive subjects who met the
inclusion criteria for study enrolment. A signed statement of informed
consent, approved by the institutional review board, was obtained
from each subject prior to subject enrolment. Criteria for inclusion
included the following: persistent AF (30 days event duration), a clini-
cal indication for electrophysiological (EP) testing with left atrial (LA)
mapping, and more than 18 years of age. The patients who did not
show re-initiation of AF after direct current (DC) shock were included
in this study. Exclusion criteria included LA thrombus or mass, history
of Maze surgery, previous AF ablation attempt(s), acute decompen-
sated congestive heart failure within 1 month of enrolment, a left ven-
tricular ejection fraction (LVEF) of ,30%, currently participating in a
clinical investigation that includes an acute treatment arm, and a life
expectancy of ,12 months.
Pre-electrophysiological study procedures
All AADs were stopped before the procedure in order to exclude the
effect of AAD(s) during the study. Class Ic drugs were discontinued for
a period corresponding to at least five half-lives, and amiodarone was
discontinued for at least 4 weeks. There was no patient who com-
plained of symptoms related to rapid ventricular response, such as pal-
pitation or chest discomfort during that period. Warfarin for
anticoagulation was orally administered (target INR: 2–3) for at least
1 month before the procedure. To exclude the presence of atrial
thrombus, transoesophageal echocardiography was performed within
48 h before the procedure.
Electrophysiological study procedure
A decapolar catheter was positioned in the high right atrium (HRA),
and a duo-decapolar catheter was inserted via a femoral vein and posi-
tioned inside the coronary sinus (CS) and along the low right atrium
(LRA, Figure 1). A quadripolar catheter was placed along the His
bundle recording region. Intracardiac electrograms were recorded
using a Prucka CardioLab
TM
Electrophysiology system (GE Medical
Systems Inc., Milwaukee, WI, USA). Before the procedure, spiral com-
puterized tomography (CT) scans of the heart with a three-
dimensional reconstruction were performed in order to accurately
define the LA anatomy. DC shocks (mean energy: 5 J) were delivered
using decapolar catheters positioned at the RA and CS, respectively,
and we confirmed the stability of the recording catheters after each
shock.3
Non-contact endocardial mapping and
electroanatomical mapping procedure
The non-contact endocardial mapping (NCM) balloon with multielec-
trode array (MEA; St Jude Medical Inc., St Paul, MN, USA) was posi-
tioned in the LA, with stability ensured with a 0.035 inch guide-wire
passing through the transseptal puncture positioned in the left superior
pulmonary veins (LSPV; Figure 1). After the double transseptal punctu-
res, anticoagulation was begun with heparin, maintaining an activated
clotting time between 350 and 400 s. The NCM mapping technique
has been described elsewhere.4–8 A three-dimensional geometry of
the LA was attained by sampling location points with the steerable
catheters in the LA, PVs, and sampling location points under the gui-
dance of fluoroscopy, angiography, CT, and the electrograms. LA
voltage and activation maps were created by the MEA catheter. Con-
currently, multiple multipolar EP catheters were placed in the RA and
the CS for electrical mapping. After electrical cardioversion of AF, a
low-voltage zone (LVZ) within the LA was determined by dynamic
substrate mapping (DSM).6 We interactively placed virtual electrodes
on the coloured map contours to analyse the corresponding non-
contact unipolar electrograms. The LVZ was defined as the area
with ,30% amplitude of non-contact unipolar electrogram peak nega-
tive potential.6 The LVZ areas attained for each sinus rhythm (SR) and
pacing at the HRA and CS were then overlaid, and the convergence of
these multiple areas correlating with a more fixed, rather than func-
tional, substrate condition, was used as the test pacing site within
the LA.9
Validation of non-contact endocardial
mapping
Besides the NCM, we also performed three-dimensional electroanato-
mical mapping using contact bipolar electrode catheter (NavX, St Jude
Medical Inc., Minnetonka, MN, USA), and the overlay LVZs of the two
mapping methods were compared. A representative example resulting
from the two different methods in the same patient is shown in
Figure 2. The multiple overlay sites in NCM were in agreement with
the low-voltage areas in contact mapping, which located at the LA
septum and LA posterior wall (Figure 2).
Pacing protocol
Pacing study at each site was first performed before AF induction test
to minimize the cumulative effects of DC shocks. SSP and LTSP with
cycle lengths (CLs) of 500 ms or 600 ms at twice the diastolic
voltage threshold were performed at the HRA, the distal CS, and
the LA at the sites showing maximal overlay of LVZs during SR. LA
pacing was performed with a 7-Fr steerable, decapolar catheter
(Polaris, Boston Scientific Corp., Natick, MA, USA). Before mapping,
at least 1 min of stable continuous capture at each pacing site with
each pacing configuration was performed to achieve steady-state con-
ditions. After the pace-mapping portion of the pacing protocol, SR was
maintained for more than 5 min in preparation for the prevention of
burst-induction of AF portion of the pacing protocol. Burst-pacing
(10 mA, 50 ms pacing CL) for 5 s was delivered to the RA while main-
taining, in turn, SSP and LTSP (500 ms or 600 ms) at each of the HRA,
CS, and LA. This AF inducibility test was conducted twice in each
patient to assess its reproducibility.
Data analysis
Atrial activation times were measured during SR and during each
pacing configuration from each test pacing site. RA activation times
were estimated as the duration between the earliest and the latest
RA catheter intracardiac electrograms. LA activation times were
measured for each pacing configuration from each test pacing site
were assessed similarly (earliest to latest activations) from the MEA
virtual electrograms. Biatrial activation times were estimated similarly
as earliest to latest activations, but taking into account the MEA and
contact electrograms. Each atrial activation time was calculated as aver-
aged over three to four consecutive beats. The pacing scheme that eli-
cited the shortest biatrial activation times was identified. P-wave
duration during SR and each pacing site and configuration was
measured in leads II and III at a paper speed of 50 mm/s. P wave dur-
ation was taken as the time interval between the earliest onset of the
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Figure 1 Fluoroscopic images show the positions of the electrodes and the multiple electrode array catheter. (A) Right anterior oblique
(RAO) 358 view. (B) Left anterior oblique (LAO) 358 view. Single- and triple-site pacing were performed by one pair and three pairs of the
bipolar electrode, respectively.
Figure 2 A representative example of simultaneous mapping with non-contact and contact electrode catheter in the same patient. (A) In
NCM system, multiple overlay of LVZ (arrows) located in the left septum and posterior wall of left atrium. (B) The area of LVZ (arrowheads)
recorded by contact bipolar electrode catheter was identified in the sites showing multiple overlay of LVZs obtained by NCM.
J.-I. Choi et al.510
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P wave and the latest offset in the same lead. We analysed how the
LVZs were affected by SSP and LTSP.
Statistical analysis
All values are expressed as mean+ standard deviation. Differences
between groups were examined by means of paired t-test, Student’s
t-test or Mann–Whitney U test, and Spearman’s correlation coeffi-
cient. A value of P, 0.05 was considered statistically significant.
Data were analysed using SPSS version 12.0 software (SPSS Inc.,
Chicago, IL, USA).
Results
Patient characteristics
The patient characteristics are shown in Table 1. Mean age was
55.2+12.7 years, and 8 of 10 patients were male. Mean AF dur-
ation was 76.9+71.9 months. The mean LA diameter on echocar-
diographic measurement was 52.0+10.9 mm and the mean LVEF
was 56.0+5.3%. As for associated cardiovascular disease, hyper-
tension was present in six patients, coronary artery disease in
two, and diabetes mellitus in one. One patient had a history of
myomectomy of the interventricular septum owing to hyper-
trophic cardiomyopathy, and one patient had a history of cerebral
embolism. The number of previously used AADs for AF averaged
2.2+ 0.9 agents. Antiarrhythmic agents used in these patients
before the study included flecainide, propafenone, or amiodarone.
A b-blocker had been used in combination with AADs (class Ic or
III) in five patients.
Multiple overlay sites on dynamic
substrate mapping
SSP and LTSP at the LA were performed at the sites showing
maximal overlay of LVZs during SR. The multiple overlay sites by
DSM were identified in all patients, which was found at the
septum in five patients, the junction between LSPV and the roof
in four patients, lateral ridge between left atrial appendage (LAA)
and left PVs in four patients, roof in four patients, left inferior pul-
monary vein (LIPV) in one patient, and posterior wall in one
patient (Table 1). The multiple overlay sites in the LA were multiple
in seven patients (two in three patients and three in four patients).
Atrial activation time
The mean twice-diastolic threshold at each test pacing site were
HRA: 1.8+1.5 mV; distal CS: 3.1+2.7 mV; and LA: 2.2+
1.3 mV. The activation times obtained at each pacing site are
shown in Table 2. The LA, RA, and biatrial activation times by
LTSP elicited from the HRA and LA were all significantly shorter
than those by SSP, respectively. LA and biatrial activation times
from the CS were only significantly shorter during LTSP compared
with SSP. In order to analyse the relation with the LA size and the
biatrial activation time, we analysed using Spearman’s correlation
coefficient. There are a trend with positive correlations between
biatrial activation times and LA size (with biatrial AT in SSP: r ¼
0.552, P ¼ 0.098; with biatrial AT in triple-site pacing: r ¼ 0.588,
P ¼ 0.074). In patients with large LA (numbers 1 and 7), atrial
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Figure 3 Representative examples of activation map during pacing. (A). During distal CS pacing, LTSP produced more uniform and linear
wave-front propagation than SSP (arrows indicated activation pattern during each pacing at distal CS). (B) Larger area was depolarized by
LTSP than by SSP.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 RA, LA, and biatrial activation time after triple-site vs. single-site pacing
Pacing site RA activation time LA activation time Biatrial activation time
Single Triple P-value Single Triple P-value Single Triple P-value
Sinus rhythm (ms) 68.6+14.8 – 75.4+16.6 – 117.8+24.2 –
HRA (ms) 109+30 97+33 0.004 81+14 76+14 0.009 183+24 174+24 0.001
CS (ms) 88+27 88+28 0.472 130+21 119+20 0.002 186+29 166+28 0.000
LA (ms) 71+16 69+16 0.013 101+34 94+33 0.001 171+40 163+39 0.002
RA, right atrial; LA, left atrial; HRA, high right atrium; CS, coronary sinus; LA, left atrium; LAA, left atrial appendage; P-value, SSP vs. LTSP.
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activation times during the LA pacing are much longer than other
patients.
Atrial activation patterns
LTSP manifested more linear and uniform wave-front propagation
compared with SSP at all test sites. LTSP also depolarized larger
areas of the LA immediately upon stimulation than SSP. Represen-
tative examples are shown in Figure 3.
P wave duration
The P wave duration was significantly shorter during LTSP than SSP
when pacing from the HRA (141.7+ 35.1 vs. 146.9+38.5 ms; P ¼
0.045), distal CS (138.1+34.6 vs. 145.7+33.7 ms; P ¼ 0.016),
and the LA (142.7+ 33.4 vs. 151.3+35.1 ms; P ¼ 0.014; Table 3).
Effects of pacing on atrial fibrillation
inducibility
Sustained LTSP delivered from the LA prevented AF induction in 3
out of 10 patients (Figure 4). This effect was reproducibly con-
firmed in each patient with a repetitive trial within 3 min,
however, sustained LTSP delivered from the HRA and CS did
not prevent AF induction in any patient. Sustained SSP from any
test pacing site did not affect AF inducibility in all patients.
Activation time in patients with atrial
fibrillation prevention
In the three patients (numbers 1, 2, and 9) who showed prevention
of AF induction during LTSP at the LA, the pacing sites are pos-
terior wall of LIPV, posterior roof, and junction between LSPV
and LAA, respectively. Biatrial activation times during TSP in
these three patients was significantly shorter than during SSP
(153.0+47.6 vs. 161.0+54.5 ms; P ¼ 0.038). There were
trends toward shortening of activation time in LA, with paradoxi-
cally its prolonging in RA, by TSP at the LA compared with those
by SSP (LA activation time: 92.3+48.1 vs. 99.3+ 53.0 ms; P ¼
0.079; RA activation time: 77.0+19.7 vs. 77.7+ 17.2 ms; P ¼
0.084).
Discussion
The main findings of this study are as follows: First, LTSP provided
for decreased biatrial and LA activation time compared with SSP;
this was confirmed by both endocardial mapping as well as P
wave duration. Second, LTSP depolarized a larger area of atrial
tissue than SSP, and produced more uniform and linear wave-front
propagation over the atria, Finally, LTSP delivered from the LA
showed some efficacy in preventing burst-induction of AF, while
SSP did not.
Effects of linear triple-site atrial pacing
Hemels et al.10,11 reported that SSP in combination with AADs
may be effective for reducing AF burden and prevention of AF in
patients without bradyarrhythmias. Ryu et al.1 investigated that
comparative effects of SSP and LTSP at the RA in a canine
model using a pacing electrode configuration comprising three
closely spaced electrodes arranged in a line and epicardial
mapping. They reported that LTSP created more uniform exci-
tation propagation over the atria compared with SSP. Furthermore,
conduction abnormalities, such as conduction block and slow con-
duction, induced by diseased myocardium, were also reduced or
eliminated by TSP, and RA-based LTSP significantly reduced the
RA and biatrial activation time compared with SSP.1 Our study is
the first study to investigate the utility of LTSP in humans, and
serves to extend the previous preclinical findings, maintaining the
potential implications. It has been demonstrated that atrial pacing
has the benefit of attenuating the burden of AF and incidence of
thrombo-embolic events compared with the accumulation of ven-
tricular pacing.12,13 Several studies have reported that dual-site bia-
trial pacing decreases the recurrence and inducibility of AF.14–18
Becker et al.2,19 showed that multisite pacing is effective for AF
suppression in an animal model by producing less functional con-
duction block with multidirectional excitation and a reduction in
total activation time. However, these studies used multisite
pacing in two or more locations far from one another, with each
location working as effectively as SSP. As suggested by Becker
et al., shortening of activation time and multidirectional excitation
may contribute to the effectiveness of multi-site pacing in AF sup-
pression. In the present human study, reduction of atrial activation
times, shortening of P wave duration, and more uniform propa-
gation were noted with LTSP compared with SSP. These findings
further support the feasibility of LTSP for AF suppression.
Linear triple-site atrial pacing at the area
of multiple overlay of low-voltage zones
The properties of the LA substrate and electroanatomical
remodelling have been known to be important in the maintenance
of AF.20,21 The development of AF sustenance may result from
increased tissue anisotrophy owing to fibrosis,21 and long-standing
AF itself may promote a progressive increase in the fibrosis of the
LA.22,23 Propagation wave break may occur in the area of scar or
LVZ which, in the setting of prolonged activation time, may result
in reentry.24 Such conduction disturbance may also increase the
dispersion of refractoriness and the heterogeneity of recovering
tissue, which may contribute to the induction and maintenance
of AF.24 In addition, the LA scarring has been reported to be a
strong predictor of procedural failure in patients undergoing radio-
frequency catheter ablation for AF.25 The non-contact unipolar
electrograms in the LVZ in this study were wide, low-amplitude,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 P wave duration during sinus rhythm and atrial
pacing: single- vs. triple-site pacing
Pacing site Single-site
pacing
Triple-site
pacing
P-value
Sinus rhythm
(ms)
125.4+22.4 –
HRA (ms) 146.9+38.5 141.7+35.1 0.045
Distal CS (ms) 145.7+33.7 138.1+34.6 0.016
LA (ms) 151.3+35.1 142.7+33.4 0.014
HRA, high right atrium; CS, coronary sinus; LA, left atrium; P-value, SSP vs. LTSP.
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and fractionated, suggesting delayed and non-uniform anisotropic
conduction through the diseased atrium, which may be associated
with atrial fibrosis.26 The overlay and convergence of multiple
areas of LVZs correlated with a more fixed rather than functional
substrate.9 This study showed that LTSP, delivered at the multiple
overlay sites of LVZs, shortened atrial activation time by
attenuation of non-uniform anisotropic conduction, which may
suppress AF. While several mechanisms underlying AF suppression
by LTSP at the LVZs may be postulated, we propose that a key may
be to prevent propagation wave break-up or perturbation of
reentry by reducing slow conduction and multidirectional, non-
uniform propagation. In our study, the pacing sites of the LA
Figure 4 Examples showing non-inducible AF while maintaining triple-site pacing at the zone of multiple overlay of the LA. (A) AF was non-
inducible during continuous triple-site pacing at the LA. (B) Induced AF was non-sustained while maintained triple-site pacing at the multiple
overlay of LVZs.
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were selected by maximal overlay of LVZs obtained by pacing at
different sites (DSM), which presumed as atrial scarring with
in-homogenecity, however, DSM was not performed at the CS
for the selection of pacing sites, just empirically from distal to prox-
imal bipoles. Furthermore, the multiple overlay sites of the LA
were mostly noted at the septum, roof, lateral ridge, etc., not at
the posterior wall or near CS. Therefore, pacing at the CS might
result in different activation pattern when compared with pacing
at the LA, and preventive LTSP in the CS did not show the same
or better results than LA LTSP in patients with posterior ‘atrial
scarring’ in view of the shorter distance and better organization
of the induced atrial activation.
Study limitations
First, the effect of LTSP in patients with paroxysmal AF was not
assessed in this study. There may be differences between paroxys-
mal and persistent AF according to the level of remodelling or the
modification of substrate which may affect conduction time or acti-
vation pattern. Second, the acute effect of LTSP in patients with
substrate-dominant AF was evaluated within a relatively short
time period. Third, even though non-contact mapping is known
to be useful and applicable in clinical fields, it is not exactly the
same as the contact electrode. Therefore, differences between
contact and non-contact electrograms may have existed, which
might have misguided the activation time and precise identification
of suitable pacing sites. Fourth, we cannot completely rule out the
possibility that DC shocks change electrophysiological parameters
during the study. Another limitation was the small sample size and
follow-up period for only short duration.
Clinical implications
Atrial pacing from the traditional RA appendage or from within the
CS, if implemented with multisite pacing, may improve AF suppres-
sion.27 There is no consistent data that support the use of alterna-
tive SSP, multisite RA pacing, biatrial pacing, therefore, at present,
permanent pacing to prevent AF is not indicated.28 Our study is
the first to investigate the usefulness of linear multisite pacing in
human, and the result of this study is expected to be helpful in clar-
ifying the potential role of linear multisite pacing for AF.
However, it still remains to be determined whether chronic LA
pacing is available in our practice. Several candidate sites for LA
pacing, such as vein of Marshall, one of the tributaries of the
cardiac veins, or direct endocardial LA, might be considered, but
further study is required. DSM, in conjunction with dynamic acti-
vation display, is useful in revealing underlying the substrate prop-
erties and their relationship with wave dynamics, and the
assessment of pacing effect at these sites may be helpful in dis-
tinguishing LVZ or scar as an effective target from bystander fibril-
latory conduction which could guide effective substrate
modification. Therefore, LTSP at these locations may be expected
to provide an effective therapeutic modality in AF suppression and
prevention through these novel pacing modalities.
Conclusions
Compared with SSP, LTSP at the HRA, CS, or LVZ of the
LA-reduced atrial activation times and P wave duration, produced
more uniform and linear wavefront propagation, and depolarized a
larger area. LTSP showed some efficacy in preventing
burst-induction of AF, and may offer an effective means of AF sup-
pression. These results warrant further clinical investigation with
larger numbers of the patients.
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